IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Acquired Hemophilia A
Peking Union Medical College Hospitalmonoclonal_antibodyPhase 4 / ApprovedDormant
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 55/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Acquired Hemophilia A cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Peking Union Medical College Hospital | Phase 4 | BB |
DARATUMUMAB Institute of Hematology & Blood Diseases Hospital, China | Phase 4 | BB |
Tak-672 Takeda | Phase 2/3 | B |
Emicizumab University of Washington | Phase 2 | B |
Bortezomib Peking Union Medical College Hospital | Phase 2 | CCC |
Obi-1 Baxalta now part of Shire | Phase 2/3 | CCC |
Susoctocog Alfa Takeda | D |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →